The field of cancer immunotherapy received an important boost last week with the FDA’s approval of the first therapeutic cancer vaccine, sipuleucel-T (Provenge). The vaccine was approved for some men with metastatic prostate cancer based on the results of a phase III randomized trial. However, because of the way in which the vaccine is produced, its availability will be very limited for at least the next 12 months.
Approval of the vaccine by the FDA is important on several levels, said Dr. Philip Kantoff, director of the Lank Center for Gen...
Read Full Post
More Posts
A tale of two T-cells
A disclaimer: I'm not a pathologist, and I doubt anyone reading this is a pathologist either. I don't assume th... Read Ross' Cancer Blog Submitted on Tue, 05/04/2010 - 10:16. Comments - 3
Nifty New Tool to Help Transfer to and from Bed Howard Bailes tells a fascinating story...
“When my wife Janice contracted MS it left her without the use of h... Read Angie's Cancer Blog Submitted on Sat, 05/01/2010 - 02:37. Comments - 0
CancerConsultants.com Changes Name and Focus CancerConsultants.com is changing its name and expanding the resources it provides to cancer patients and their fam... Read Angie's Cancer Blog Submitted on Wed, 04/28/2010 - 14:46. Comments - 0
The OMG! Cancer Summit Are you a young adult between the ages of 15 and 39 who has been affected by cancer? Are you a caregiver or provide... Read Angie's Cancer Blog Submitted on Mon, 04/26/2010 - 14:54. Comments - 0
Upcoming Free Teleconferences Childhood Leukemia and Lymphoma: Update on Treatment and Follow-up Care
Tuesday May 4, 2010
1:00 pm - 2:00 p... Read Angie's Cancer Blog Submitted on Sun, 04/25/2010 - 16:51. Comments - 0
One More Reason to Eat Leafy Greens In the first study of vitamin K and Non-Hodgkin lymphoma : ( www.mayoclinic.org/non-hodgkins-lymphoma/ : ) risk, ... Read Angie's Cancer Blog Submitted on Thu, 04/22/2010 - 21:51. Comments - 0
David Burns, a story of fighting David Burns is a lover and a fighter. Even before his initial diagnosis with acute myelogenous leukemia (AML) at ag... Read Angie's Cancer Blog Submitted on Wed, 04/21/2010 - 13:29. Comments - 0
The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
More Information
SupportGroups.com
SupportGroups.com is for individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Improved diagnosis has contributed greatly to the increase as doctors better understand cancer of lymphocytes and can distinguish it from other diseases.
